Soleno Therapeutics (SLNO) had the highest return between September 13, 2023 and January 2, 2024 by a mid-cap US stock, returning 858.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/13/2023 - 1/2/2024 | 858.33% |
Immunitybio (IBRX) | 9/13/2023 - 1/2/2024 | 201.15% |
Scholar Rock (SRRK) | 9/13/2023 - 1/2/2024 | 181.8% |
CleanSpark (CLSK) | 9/13/2023 - 1/2/2024 | 147.27% |
Cytokinetics (CYTK) | 9/13/2023 - 1/2/2024 | 139.79% |
Ramaco Resources (METC) | 9/13/2023 - 1/2/2024 | 121.74% |
Ondas (ONDS) | 9/13/2023 - 1/2/2024 | 111.63% |
Applied Opt (AAOI) | 9/13/2023 - 1/2/2024 | 91.69% |
Immunovant (IMVT) | 9/13/2023 - 1/2/2024 | 90.39% |
Gap (GAP) | 9/13/2023 - 1/2/2024 | 90.35% |
Xometry (XMTR) | 9/13/2023 - 1/2/2024 | 79.31% |
Mercurity Fintech Holding Inc ADR (MFH) | 9/13/2023 - 1/2/2024 | 79.29% |
Frontier Communications Parent (FYBR) | 9/13/2023 - 1/2/2024 | 77.46% |
Rhythm Pharmaceuticals (RYTM) | 9/13/2023 - 1/2/2024 | 75.95% |
Spirit Aerosystems (SPR) | 9/13/2023 - 1/2/2024 | 75.77% |
Abercrombie & Fitch (ANF) | 9/13/2023 - 1/2/2024 | 74.65% |
Compania de Minas Buenaventura SAA ADR (BVN) | 9/13/2023 - 1/2/2024 | 73.55% |
Macy’s (M) | 9/13/2023 - 1/2/2024 | 72.54% |
Companhia Siderurgica Nacional ADR (SID) | 9/13/2023 - 1/2/2024 | 67.77% |
HCI (HCI) | 9/13/2023 - 1/2/2024 | 65.71% |
TAL Education (TAL) | 9/13/2023 - 1/2/2024 | 65.13% |
F&G Annuities & Life (FG) | 9/13/2023 - 1/2/2024 | 63.82% |
Liquidia Technologies (LQDA) | 9/13/2023 - 1/2/2024 | 63.55% |
Arcellx (ACLX) | 9/13/2023 - 1/2/2024 | 63.37% |
Nuvalent (NUVL) | 9/13/2023 - 1/2/2024 | 62.02% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
